We have shown that ERAP1 overtrimming can have a significant impact on anti-tumor immunity in a preclinical model, where reduction of ERAAP protein in the murine CT26 tumor significantly increased generation of the immunodominant cryptic epitope (18). Here, ERAP1 is linked to neoplasm.